Or follow me on Twitter or LinkedIn and stay in touch.
Anne-Marie van Geloven
|
In 2012 I've launched an innovative medical grade eye lift strip called . It's the first and only product developed for Lily Leading Instant Eye Lift, botulinum toxin related ptosis (droopy eyelid) which became increasingly popular to use for create a temporary eye lift by makeup artists and customers with aging or hanging upper eyelids. Lily Leading Instant Eye Lift is sold in my online shop. Ever since, I started blogging more often about cosmetic related topics and of course injectables like botulinum toxin and dermal fillers. Here is the link to my new blog. I hope you'll visit me there to read my latest online articles.
Or follow me on Twitter or LinkedIn and stay in touch. Anne-Marie van Geloven
2 Comments
Currently there is an important discussion ongoing about the potential health risk for consumers regarding the use of medical devices like breast implants or facial fillers. Some even suggest that facial fillers could be the next cosmetic surgery scandal.
Implants and facial fillers are both medical devices, meaning there are different rules and regulations that apply than for prescription drug like botulinum toxins. Read more - click here The biggest difference between implants, like the PIP implants and facial fillers, is that the current facial fillers do not contain silicones, but most often Hyaluronic Acid sometimes combined with Lidocaine.. The effect of Hyaluronic Acid can be completely reversed with Hyaluronidase Fillers containing collagen are no longer available. Read more. Other fillers more common used contain Poly L Lactic Acid, Calcium Hydroxylapatite and a different technology called Autologous Cell Therapy . The most important similarity between the use implants and facial fillers is that they only should be used by well trained and skilled professionals. Facial fillers currently are not only provided by educated and trained physicians and world wide there is a demand to regulate this much better to be able to ensure all consumers safety, comfort and desired results in a professional environment done by a well trained physician, who is also able to provide good information, advice, follow up and eventually is able to handle complications and complaints. If you want to look your best, make sure to go to the best, and facial fillers will not be the next cosmetic surgery scandal. How to prepare yourself for your appointment More information about injectables, specifically botulinum toxins: 9 things to consider before you make the appointment The Leading Injectable Centers of the World® Quality in Beauty Nonanimal, stabilized hyaluronic acid (NASHA) gels have become a very popular dermal filler material. In the past, if an error was made in filler quantity or placement, the solution was to wait for the material to reabsorb over several months. Hyaluronidase may have the potential to speed resorption by breaking up the gel. To evaluate hyaluronidase's effects on previously implanted NASHA gel, these researchers performed a two-part, prospective, randomized, sequential study.
In the first part, 12 healthy volunteers had 0.2 mL of NASHA gel injected into two sites, approximately 10 cm apart, on one forearm. One to 3 days after implantation, a blinded evaluator graded the cutaneous augmentation at both sites, and 75 units of hyaluronidase with thimerosal preservative were injected into one site and control saline into the other. Within 4 to 7 days of hyaluronidase injection, 80% of the NASHA gel had clinically disappeared at the hyaluronidase site, while 90% of the gel persisted at the control site. Fourteen days later, the median skin score at the hyaluronidase sites was 0 -- no clinically detectable gel. The second part of the study was designed to measure the dose-dependent effects of hyaluronidase. Eight new volunteers received three 0.2-mL injections of NASHA gel, 3 cm apart, on one forearm. Three to 5 days later, a different concentration of preservative-free hyaluronidase (10, 20, or 30 units) was injected into each of the three implantation sites in each subject. Four to 7 days later, the 30-U sites had no palpable gel, and the 20-U and 10-U sites demonstrated dose-dependent reductions. By 14 days, the 20-U sites became clinically imperceptible, and by 4 weeks, the 10-U sites became imperceptible as well. About 25% of subjects in both parts of the study developed localized allergic reactions in the hyaluronidase-injected sites; the reaction was more pronounced with injections containing thimerosal. Comment: Hyaluronidase injections were useful in reducing NASHA gel overcorrection. The desired level of flattening can be achieved by carefully titrating the dose, and larger doses completely eliminate NASHA gel effect from the implantation site. The injection can be done several days after implantation, when the procedure-associated edema has mostly resolved. Localized allergic reactions to hyaluronidase were frequent at the doses used. Patients with a history of allergy to bee venom or to the preservative should not be injected. George J. Hruza, MD Published in Journal Watch Dermatology August 9, 2005 References: Vartanian AJ et al. Injected hyaluronidase reduces restylane-mediated cutaneous augmentation. Arch Facial Plast Surg 2005 Jul/Aug; 7:231-7. Original article (Subscription may be required) Medline abstract (Free) The Leading Injectable Centers of the World® Quality in Beauty |